In the September 2019 issue of Nature Biotechnology, a collective of scientists mostly from Insilico Medicine, led by Alex Zhavoronkov, CEO and founder of the company, published a landmark article.
In the September 2019 issue of Nature Biotechnology, a collective of scientists mostly from Insilico Medicine, led by Alex Zhavoronkov, CEO and founder of the company, published a landmark article.